P R Streeter
Overview
Explore the profile of P R Streeter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
1651
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gold M, Eid T, Smyk-Pearson S, Eberling Y, Swarbrick G, Langley S, et al.
Mucosal Immunol
. 2012 Jun;
6(1):35-44.
PMID: 22692454
Human mucosal-associated invariant T (MAIT) cells express the semi-invariant T-cell receptor (TCR) Vα7.2 and are restricted by the major histocompatibility complex-Ib molecule MR1. While MAIT cells share similarities with other...
2.
Dorrell C, Schug J, Lin C, Canaday P, Fox A, Smirnova O, et al.
Diabetologia
. 2011 Sep;
54(11):2832-44.
PMID: 21882062
Aims/hypothesis: We sought to determine the mRNA transcriptome of all major human pancreatic endocrine and exocrine cell subtypes, including human alpha, beta, duct and acinar cells. In addition, we identified...
3.
Adkisson H, Milliman C, Zhang X, Mauch K, Maziarz R, Streeter P
Stem Cell Res
. 2009 Nov;
4(1):57-68.
PMID: 19880363
Degeneration of joint articular cartilage is a leading cause of disability worldwide, and is due in large part to the fact that adult articular cartilage is unable to undergo effective...
4.
Pre-clinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cells
Kovacsovics-Bankowski M, Mauch K, Raber A, Streeter P, Deans R, Maziarz R, et al.
Cytotherapy
. 2008 Nov;
10(7):730-42.
PMID: 18985479
Background: Successful clinical development of novel cellular therapeutics requires the evaluation of clinical acute toxicity endpoints in scoring patient adverse events (AE) contributing to dose-limiting toxicity (DLT) for establishment of...
5.
Chipps T, Streeter P, Franc D, Neumeyer K, Planck S, Rosenbaum J, et al.
J Immunol Methods
. 2006 May;
312(1-2):209-13.
PMID: 16725152
In the human host, infection with the protozoan parasite, Toxoplasma gondii, most commonly involves the eye and/or the brain. Previous work indicates a relative susceptibility of the human retinal vascular...
6.
Fleming W, Mulcahy J, McKearn J, Streeter P
Exp Hematol
. 2001 Aug;
29(8):943-51.
PMID: 11495700
Objective: Progenipoietin-1 is an agonist of both the granulocyte colony-stimulating factor and fetal liver tyrosine kinase-3 receptors capable of inducing the proliferation of multiple hematopoietic cell lineages. The potential of...
7.
Ishioka G, Fikes J, Qin M, Gianfrani C, Chesnut R, Kahn L, et al.
Vaccine
. 2001 Jun;
19(27):3710-9.
PMID: 11395205
Recently, a dual receptor agonist for human Flt3 and G-CSF receptors, progenipoietin-4 (ProGP-4), was shown to be highly effective in expanding DC in vivo. In this study, we examined the...
8.
Streeter P, Minster N, Kahn L, Hood W, Vickery L, Thurman T, et al.
Exp Hematol
. 2001 Feb;
29(1):41-50.
PMID: 11164104
The progenipoietins, a class of engineered proteins containing both fetal liver tyrosine kinase-3 and granulocyte colony-stimulating factor receptor agonist activities, were functionally characterized in vitro and in vivo. Four representative...
9.
Okuyama S, Rubin D, Streeter P, Peters M
Gastroenterology
. 1997 Apr;
112(4):1241-9.
PMID: 9098008
Background & Aims: Recirculation of lymphocytes requires appropriate signals on the lymphocytes as well as the vascular endothelium. The aim of this report was to study the expression of the...
10.
Shailubhai K, Streeter P, Smith C, Jacob G
Glycobiology
. 1997 Mar;
7(2):305-14.
PMID: 9134437
Leukocyte recruitment from blood into peripheral lymph nodes is controlled in part by a specific interaction of lymphocyte-associated L-selectin with endothelial cell receptors known as peripheral addressins. In murine lymph...